Bernard D. King

Chemistry, structure and function of approved oligonucleotide therapeutics

Nitric oxide signaling in health and disease

58 FINAL RESULTS – RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY, ANTI-VIRAL PROOF-OF-CONCEPT STUDY OF MIRAVIRSEN, AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION

Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs.